CRNX Short Interest

Crinetics Pharmaceuticals, Inc. (CRNX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.01B, listed on NASDAQ, employing roughly 594 people, carrying a beta of 0.13 to the broader market. Crinetics Pharmaceuticals, Inc. Led by R. Scott Struthers, public since 2018-07-18.

Short interest is the total number of shares currently sold short and not yet covered, reported twice monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.

Settlement Date

2026-08-31

Short Interest

6.8M

Previous Short Interest

6.6M

Change

3.92%

Days to Cover

2.39

Avg Daily Volume

2.9M

Avg Days to Cover (24 reports)

10.02

Showing 24 twice-monthly FINRA short interest reports for Crinetics Pharmaceuticals, Inc..

Learn how short interest is reported and how to read the data →